Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong-Reference-Cited by-同舟云学术

Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong

Published:2023-03 Issue: Volume:32 Page:100660
ISSN:2666-6065
Container-title:The Lancet Regional Health - Western Pacific
language:en
Short-container-title:The Lancet Regional Health - Western Pacific

Author:

Zhou Runhong,Liu Na,Li Xin,Peng Qiaoli,Yiu Cheuk-Kwan,Huang Haode,Yang Dawei,Du Zhenglong,Kwok Hau-Yee,Au Ka-Kit,Cai Jian-Piao^ORCID,Fan-Ngai Hung Ivan,Kai-Wang To Kelvin,Xu Xiaoning^ORCID,Yuen Kwok-Yung,Chen Zhiwei^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Psychiatry and Mental health,Geriatrics and Gerontology,Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Health Policy,Pediatrics, Perinatology and Child Health,Internal Medicine

Reference60 articles.

1. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

3. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2021

4. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey;Tanriover;Lancet,2021

5. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial;Xia;Lancet Infect Dis,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of vaccine type and booster dose on the magnitude and breadth of SARS-CoV-2-specific systemic and mucosal antibodies among COVID-19 vaccine recipients;Heliyon;2024-08

2. Population Behavior Changes Underlying Phasic Shifts of SARS-CoV-2 Exposure Settings Across 3 Omicron Epidemic Waves in Hong Kong: Prospective Cohort Study;JMIR Public Health and Surveillance;2024-06-19

3. Dynamic immune landscape in vaccinated-BA.5-XBB.1.9.1 reinfections revealed a 5-month protection-duration against XBB infection and a shift in immune imprinting;eBioMedicine;2024-01

4. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study;Journal of Infection;2023-12

5. Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination;Human Vaccines & Immunotherapeutics;2023-11-28